PF-03049423
PF-03049423 (Compound PF-5) is a potent and highly selective phosphodiesterase-5A inhibitor with an IC50 of about 0.2 nM for rat and human platelet enzyme. PF-03049423 can be used for the research of acute ischaemic stroke.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 402955-58-2
- Formel: C24H32N6O4.xHCl
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
PDE5A |
rat and human platelet enzyme ~0.2 nM (IC50) |
In Vivo
PF-03049423 (1.0 mg/kg b.i.d. or 0.6 mg/kg q.d. for 7 days) improves poststroke sensory–motor behavioral outcome even when the treatment is initiated 24-72 hours after occlusion[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Sprague-Dawley rats, middle cerebral artery occlusion (MCA-o) model[1]
-
Dosage:0.1, 1, or 10 mg/kg
-
Administration:Subcutaneous injection, b.i.d. for 7 days
-
Result:Improved functional recovery at 1 mg/kg and 10 mg/kg.
Chemical Information
-
CAS. Nr. 402955-58-2
-
Formel C24H32N6O4.xHCl
-
SMILES
O=C1C(N2CCN(CC2)CCO)=NC3=C(N1CCOCCC)C=C(C4=CC=C(OC)N=C4)N=C3.[x HCl]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)